Exploring interpretable echo analysis using self-supervised parcels.

Journal: Computers in biology and medicine
Published Date:

Abstract

The application of AI for predicting critical heart failure endpoints using echocardiography is a promising avenue to improve patient care and treatment planning. However, fully supervised training of deep learning models in medical imaging requires a substantial amount of labelled data, posing significant challenges due to the need for skilled medical professionals to annotate image sequences. Our study addresses this limitation by exploring the potential of self-supervised learning, emphasising interpretability, robustness, and safety as crucial factors in cardiac imaging analysis. We leverage self-supervised learning on a large unlabelled dataset, facilitating the discovery of features applicable to a various downstream tasks. The backbone model not only generates informative features for training smaller models using simple techniques but also produces features that are interpretable by humans. The study employs a modified Self-supervised Transformer with Energy-based Graph Optimisation (STEGO) network on top of self-DIstillation with NO labels (DINO) as a backbone model, pre-trained on diverse medical and non-medical data. This approach facilitates the generation of self-segmented outputs, termed "parcels", which identify distinct anatomical sub-regions of the heart. Our findings highlight the robustness of these self-learned parcels across diverse patient profiles and phases of the cardiac cycle phases. Moreover, these parcels offer high interpretability and effectively encapsulate clinically relevant cardiac substructures. We conduct a comprehensive evaluation of the proposed self-supervised approach on publicly available datasets, demonstrating its adaptability to a wide range of requirements. Our results underscore the potential of self-supervised learning to address labelled data scarcity in medical imaging, offering a path to improve cardiac imaging analysis and enhance the efficiency and interpretability of diagnostic procedures, thus positively impacting patient care and clinical decision-making.

Authors

  • Sylwia Majchrowska
    Wrocław University of Science and Technology, wybrzeże Stanisława Wyspiańskiego 27, 50-370 Wrocław, Poland. Electronic address: sylwia.majchrowska@pwr.edu.pl.
  • Anders Hildeman
    Data Science & Advanced Analytics, Data Science & AI, BioPharma R&D, AstraZeneca, Pepparedsleden 1, Mölndal, 431 83, Sweden.
  • Ricardo Mokhtari
    Centre for AI, Data Science & AI, BioPharma R&D, AstraZeneca, Av. Diagonal 615, Les Corts, Barcelona, 08028, Spain.
  • Tom Diethe
    Centre for AI, Data Science & AI, BioPharma R&D, AstraZeneca, Biomedical Campus, 1 Francis Crick Ave, Trumpington, Cambridge, CB2 0AA, UK.
  • Philip Teare
    Zebra Medical Vision LTD, Shfayim, Israel.